-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's After-Market Session
Share
Listen to the news

Gainers

  • GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million.
  • Greenland Mines (NASDAQ:GRML) shares increased by 10.09% to $12.32. The company's market cap stands at $44.9 million.
  • Bone Biologics (NASDAQ:BBLG) stock rose 8.57% to $0.55. The company's market cap stands at $1.3 million.
  • Senti Biosciences (NASDAQ:SNTI) stock increased by 7.95% to $0.36. The company's market cap stands at $9.8 million.
  • BioRestorative Therapies (NASDAQ:BRTX) stock rose 6.92% to $2.78. The company's market cap stands at $3.5 million.
  • Armata Pharmaceuticals (AMEX:ARMP) stock increased by 6.86% to $3.89. The company's market cap stands at $156.1 million.

Losers

  • Artelo Biosciences (NASDAQ:ARTL) shares declined by 21.5% to $5.74 during Wednesday's after-market session. The company's market cap stands at $2.2 million.
  • Silexion Therapeutics (NASDAQ:SLXN) shares fell 21.22% to $0.25. The company's market cap stands at $2.1 million.
  • Aclarion (NASDAQ:ACON) shares decreased by 15.65% to $2.48. The company's market cap stands at $7.5 million.
  • Geovax Labs (NASDAQ:GOVX) shares declined by 8.74% to $0.34. The company's market cap stands at $1.8 million.
  • Jaguar Health (NASDAQ:JAGX) stock fell 8.53% to $8.15. The market value of their outstanding shares is at $17.9 million.
  • Viking Therapeutics (NASDAQ:VKTX) stock fell 8.17% to $38.25. The company's market cap stands at $4.7 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending